Shrikhande, Alka

Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 930

Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

Rollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 162

Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect

Rollema, H., Guanowsky, V., Mineur, Y. S., Shrikhande, A., Coe, J. W., Seymour, P. A., & Picciotto, M. R. (2009) · European Journal of Pharmacology

Treatment of Major DepressionNicotinic Acetylcholine Receptors Study

Cited by 87